Source: Annual Congress 2012 - Life's a gas: aspects of respiratory gas exchange
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. A. Rutter, J. A. Colbourne, J. P. Fuld, K. P. Sylvester (Cambridge, United Kingdom). Are 6MWD and FEV1 the most clinically relevant measures?. Eur Respir J 2012; 40: Suppl. 56, 4335

Member's Comments

No comment yet.

Related content which might interest you: Is 6-min walk distance more helpful than FEV1 in evaluating severe COPD patients? Source: ISSN=ISSN 1810-6838, ISBN=, page=68 Year: 2007 PROMS and FEV1 as predictors of AECOPD Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Impact of baseline desaturation during a six minute walk test (6MWT) on prognostic value of subsequent changes in FVC and DLCO Source: Eur Respir J 2006; 28: Suppl. 50, 828s Year: 2006 Spirometric changes in bronchodilation tests as predictors of asthma diagnosis and treatment response in patients with FEV1 =80% predicted Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Rate of FEV1 decline by FEV1 percent predicted in UPLIFT® and TIOSPIR® Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Should we use gait speed in COPD, FEV1 in frailty and dyspnoea in both? Source: Eur Respir J 2016; 48: 315-319 Year: 2016 Correlation of various parameters with FEV1 in the assessment of asthma severity Source: Eur Respir J 2001; 18: Suppl. 33, 51s Year: 2001 Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Duration and frequency of spirometry needed to accurately reflect longitudinal change of FEV1 in COPD Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases Year: 2021 Relationship between IL-6 and FEV1 interaction and six minute walk distance (6MWD) performance in COPD patients Source: Annual Congress 2008 - Physiological response to exercise performance Year: 2008 Changes in spirometry (FVC and FEV1) in a closed population of COPD patients using new standarized values for Mexican people Source: Eur Respir J 2003; 22: Suppl. 45, 69s Year: 2003 Within session variability of FEV1 and FVC pre- and post-bronchodilation Source: International Congress 2019 – Quality, performance and interpretation of lung function testing Year: 2019 Spirometric diagnosis of COPD: is postbronchodilator test reliable? Source: Eur Respir J 2006; 28: Suppl. 50, 39s Year: 2006 Correlation of airway obstruction and patient-reported endpoints in clinical studies Source: Eur Respir J 2001; 17: 220-224 Year: 2001 1 year RV/TLC change as a predictor of long term decline of FEV1 Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Pre- and post-bronchodilator spirometric values and the degree of reversibility in patients with COPD Source: Eur Respir J 2004; 24: 332 Year: 2004 Perception of a significant FEV1 fall in children Source: Eur Respir J 2004; 24: Suppl. 48, 272s Year: 2004 The relationship between long-term correlations (self-similarity) in PEF and FEV1 in COPD Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012 FEV6: a useful outcome measure of lung function in COPD as assessed in a large clinical study with roflumilast Source: Eur Respir J 2004; 24: Suppl. 48, 342s Year: 2004 Does an acute FEV1 response predict long-term improvements with bronchodilators in patients with COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001